IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Weber Steven
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Takimoto Chris H
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Tahir Misbah
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Schwarzer Fred
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Keyt Bruce
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Harler Mary Beth
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Decker Lisa Lynn
IGM Biosciences | SC TO-C: Written communication relating to an issuer or third party tender offer
IGM Biosciences | 8-K: Current report
IGM Biosciences | 8-K: IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
IGM Biosciences | 10-Q: Quarterly report
IGM Biosciences | DEF 14A: Definitive information statements
IGM Biosciences | ARS: Annual Report to Security Holders
IGM Biosciences | DEFA14A: Others
IGM Biosciences | 3: Initial statement of beneficial ownership of securities-Officer Harler Mary Beth
IGM Biosciences | 8-K: Current report
IGM Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Lee Michael Stewart
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Topsoe Jakob Haldor
IGM Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Topsoe Christina Teng
No Data